WithdrawnNCT00621634
Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
Placebo comparisonAges 30–75CanadaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 30 years to 75 years.
- Listed locations
- Montreal and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: February 2008
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Université de Montréal
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Dietary supplement
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 30 Years to 75 Years
- Official registry ID
- NCT00621634
- Official title
Show the full official title
Randomized, Double-blind, Placebo-controlled Trial on the Efficacy of Omega-3 Supplementation With Docosahexaenoic Acid (DHA) on Tardive Dyskinesia
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Université de Montréal, a university.
Who can participate?
Listed age limits: 30 years to 75 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
